3-carboxy2-oxo-1 -pyrrolidine derivatives and their uses

Details for Australian Patent Application No. 2006322297 (hide)

Owner UCB Pharma, S.A.

Inventors Schule, Arnaud; Ates, Celal

Agent Watermark

Pub. Number AU-A-2006322297

PCT Pub. Number WO2007/065634

Priority 05026694.9 07.12.05 EP

Filing date 5 December 2006

Wipo publication date 14 June 2007

International Classifications

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/065634 Priority application(s): WO2007/065634

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322301-Matrix-controlled transdermal system comprising salts of ACE inhibitor dicarboxylic acids

2006322282-Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer